Global Craniomaxillofacial Devices Market 2016-2020
About Intracranial Injury
An intracranial injury, also referred to as traumatic brain injury (TBI), is a substantial head injury that can damage the brain. Every year, more than 12 million cases of TBI are reported worldwide, of which more than 1.5 million are reported in the US and 1.5-2 million in the UK. Sports-related injuries and road traffic and work accidents are some of the most common causes of TBI. Road accidents account for 50% of all TBIs, vehicle crashes, as well as pedestrians hit by vehicles.
Technavio’s analysts forecast the global craniomaxillofacial (CMF) devices market to grow at a CAGR of 6.50% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global craniomaxillofacial (CMF) devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of CMF devices.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Craniomaxillofacial (CMF) Devices Market 2016-2020
Technavio recognizes the following companies as the key players in the global craniomaxillofacial (CMF) devices market: DePuy Synthes, Stryker, and Zimmer Biomet.
Other Prominent Vendors in the market are: Aesculap, Anatomics, B. Braun, BIOPORE Surgical Implants, Ceremed, CONMED, CUSMED, HyperBranch Medical Technology, Integra LifeSciences Holdings, Kelyniam Global, KLS Martin, Matrix Surgical USA, Medartis, Medtronic, NanoNerve’s Dural Substitute, OsteoMed, Osteotec, Poriferous, Rebstock Instruments, and TMJ Concepts.
Commenting on the report, an analyst from Technavio’s team said: “Growing demand for bioresorbable devices will be a key trend for market growth. For CMF internal fixation, metals are majorly used in plating systems. In recent years, for the repair of skull fractures, reconstructive materials and techniques have gained prominence among CMF manufacturers. In CMF surgeries where metallic wires, screws and plates are involved, patients would require another procedure to remove them once the skull bones get fixed. But in case of CMF surgeries where bioresorbable devices like biodegradable wires, screws, and plates are involved, patients do not require another surgery. This proves to be economical and less painful for patients undergoing these surgeries.”
According to the report, one of the key drivers for market growth will be research collaboration between manufacturers and medical professionals for customized products. The success of a cranial reconstruction surgery depends on the focus on the reconstruction of the skull as well as the overlying soft tissue. The conventional methods of cranial reconstruction focus more on bone reconstruction and less on the soft tissue, which determines the cosmetic outcome of the surgery. If the reconstruction of soft tissue is not according to the anatomy of the skull, it can lead to a visible deformity post-surgery called persistent temporal hollowing. So, vendors are collaborating with healthcare practitioners to increase the efficiency of cranial reconstruction surgeries and improve customer satisfaction. Vendors invest in research funding and facilities while the specialists offer their experience and knowledge. The outcomes of such collaborations will improve the patient outcomes in CMF surgeries.
Further, the report states that low success rate of surgical procedures will be a challenge for the market. The common complications that arise after the procedures include misplacement of plates with screws becoming loose, infections, inflammation, limitations in facial movements, and uncomfortable sleep. In some cases, repetition of procedure becomes mandatory to avoid further unfavorable effects, and this becomes a financial burden on the person concerned. In a comparative CMF implantation study, the success rate was only 35% for metallic device implantations as compared with 85% for biodegradable implantations. Metallic implantations have been in use largely, but in recent times, biodegradable devices are gaining attention due to proven success rate, as evident from various clinical studies.
DePuy Synthes, Stryker, Zimmer Biomet, Aesculap, Anatomics, B. Braun, BIOPORE Surgical Implants, Ceremed, CONMED, CUSMED, HyperBranch Medical Technology, Integra LifeSciences Holdings, Kelyniam Global, KLS Martin, Matrix Surgical USA, Medartis, Medtronic, NanoNerve’s Dural Substitute, OsteoMed, Osteotec, Poriferous, Rebstock Instruments, TMJ Concepts.